There might be massive upside ahead for these drugmakers.
In this week’s episode of “The Top Line,” Fierce checks in with professional services juggernaut KPMG on the biopharma ...
Like many Americans, President Biden tested positive for COVID-19 last month. But, following his infection, Biden experienced something a little less common: Paxlovid rebound. Biden initially tested ...
With COVID-19 infections becoming more common, experts have recently urged doctors to prescribe the antiviral drug Paxlovid more than they have been to minimize patients’ symptoms and reduce the ...
The CDC described COVID-19 rebound cases as "a recurrence of symptoms or a new positive viral test after having tested negative" in guidance released in May Glenn Garner is a form writer-reporter who ...
Experts say even with rebound risk, drug still critical for high-risk patients. Six months ago, Dr. Joseph Boselli said he was prescribing the antiviral drug Paxlovid to nearly everyone who turned up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results